Form D · Other Technology

CELLUFUN INC

New York, NY · CIK 0001392044

Offering snapshot reported Apr 6, 2012 · SEC filing

Reported sold
$1.51M
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 23, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 6, 2012Initial$1,514,076No comparison1SEC filing
Feb 1, 2010Initial$720,000No comparison1SEC filing
Jul 27, 2009Initial$1,200,000No comparison1SEC filing
Apr 13, 2009Initial$1,580,000No comparisonNot reportedSEC filing
Oct 27, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 19, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Feb 28, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-176295

Source: Form D, filed Apr 6, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nilanjana Bhowmik Director
Kevin Cahill Executive
Stephen Dacek Executive
Neil Edwards Director, Executive
Arthur Goikhman Director, Executive
Lon Otremba Director, Executive
James J. Savage Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
120 Broadway, 33 Rd Floor
New York, NY, 10271